Advertisement

Biological Trace Element Research

, Volume 167, Issue 2, pp 225–235 | Cite as

The Association Between Serum Levels of Selenium, Copper, and Magnesium with Thyroid Cancer: a Meta-analysis

  • Fei Shen
  • Wen-Song Cai
  • Jiang-Lin Li
  • Zhe Feng
  • Jie CaoEmail author
  • Bo XuEmail author
Article

Abstract

There are conflicting reports on the correlation between serum levels of selenium (Se), copper (Cu), and magnesium (Mg) with thyroid cancer. The purpose of the present study is to clarify the association between Se, Cu, and Mg levels with thyroid cancer using a meta-analysis approach. We searched articles indexed in PubMed published as of January 2015 that met our predefined criteria. Eight eligible articles involving 1291 subjects were identified. Overall, pooled analysis indicated that subjects with thyroid cancer had lower serum levels of Se and Mg, but higher levels of Cu than the healthy controls [Se: standardized mean difference (SMD) = −0.485, 95% confidence interval (95%CI) = (−0.878, −0.092), p = 0.016; Cu: SMD = 2.372, 95%CI = (0.945, 3.799), p = 0.001; Mg: SMD = −0.795, 95%CI = (−1.092, −0.498), p < 0.001]. Further subgroup analysis found lower serum levels of Se in thyroid cancer in Norway [SMD = −0.410, 95%CI = (−0.758, −0.062), p = 0.021] and Austria [SMD = −0.549, 95%CI = (−0.743, −0.355), p < 0.001], but not in Poland (SMD = −0.417, 95%CI = (−1.724, 0.891), p = 0.532]. Further subgroup analysis also found that patients with thyroid cancer had higher serum levels of Cu in China [SMD = 1.571, 95%CI = (1.121, 2.020), p < 0.001] and Turkey [SMD = 0.977, 95%CI = (0.521, 1.432), p < 0.001], but not in Poland [SMD = 3.471, 95%CI = (−0.056, 6.997], p = 0.054]. In conclusion, this meta-analysis supports a significant association between serum levels of Se, Cu, and Mg with thyroid cancer. However, the subgroup analysis found that there was significant effect modification of Se, Cu levels by ethnic, like China and Poland. Thus, this finding needs further confirmation by a trans-regional multicenter study to obtain better understanding of causal relationship between Se, Cu, and Mg with thyroid cancer of different human races or regions.

Keywords

Selenium Copper Magnesium Thyroid cancer Meta-analysis 

Notes

Acknowledgments

The project was supported by the Guangzhou medicine and health care technology projects (20141A011011).

Conflict of Interest

The authors report no conflict of interest.

Supplementary material

12011_2015_304_Fig5_ESM.gif (63 kb)
Supplement Material Figure S1

Newcastle-Ottawa Scale (NOS) (GIF 63 kb)

12011_2015_304_MOESM1_ESM.tif (1.9 mb)
High resolution image (TIFF 1992 kb)

References

  1. 1.
    Margalioth EJ, Schenker JG, Chevion M (1983) Copper and zinc levels in normal and malignant tissues. Cancer 52:868–872CrossRefPubMedGoogle Scholar
  2. 2.
    Zaichick V, Tsyb AF, Vtyurin BM (1995) Trace elements and thyroid cancer. Analyst 120:817–821CrossRefPubMedGoogle Scholar
  3. 3.
    Cayir A, Doneray H, Kurt N, Orbak Z, Kaya A et al (2014) Thyroid functions and trace elements in pediatric patients with exogenous obesity. Biol Trace Elem Res 157:95–100CrossRefPubMedGoogle Scholar
  4. 4.
    Gumulec J, Masarik M, Adam V, Eckschlager T, Provaznik I et al (2014) Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS One 9:e99790PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Arthur JR, Beckett GJ (1999) Thyroid function. Br Med Bull 55:658–668CrossRefPubMedGoogle Scholar
  6. 6.
    Duntas LH (2006) The role of selenium in thyroid autoimmunity and cancer. Thyroid 16:455–460CrossRefPubMedGoogle Scholar
  7. 7.
    Blaszczyk U, Duda-Chodak A (2013) Magnesium: its role in nutrition and carcinogenesis. Rocz Panstw Zakl Hig 64:165–171PubMedGoogle Scholar
  8. 8.
    Dragutinovic VV, Tatic SB, Nikolic-Mandic SD, Tripkovic TM, Dunderovic DM et al (2014) Copper as ancillary diagnostic tool in preoperative evaluation of possible papillary thyroid carcinoma in patients with benign thyroid disease. Biol Trace Elem Res 160:311–315CrossRefPubMedGoogle Scholar
  9. 9.
    Jonklaas J, Danielsen M, Wang H (2013) A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid 23:1079–1086PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Li X, Ding J, Li X, Ba C, Duan A et al (2006) Clinical value of determination of trace elements in serum in breast cancer. Inner Mongolia Med J 38:799–800Google Scholar
  11. 11.
    Kohrle J (2005) Selenium and the control of thyroid hormone metabolism. Thyroid 15:841–853CrossRefPubMedGoogle Scholar
  12. 12.
    Harris ED (2001) Copper homeostasis: the role of cellular transporters. Nutr Rev 59:281–285CrossRefPubMedGoogle Scholar
  13. 13.
    Araya M, Pizarro F, Olivares M, Arredondo M, Gonzalez M et al (2006) Understanding copper homeostasis in humans and copper effects on health. Biol Res 39:183–187CrossRefPubMedGoogle Scholar
  14. 14.
    Bonham M, O’Connor JM, Hannigan BM, Strain JJ (2002) The immune system as a physiological indicator of marginal copper status? Br J Nutr 87:393–403CrossRefPubMedGoogle Scholar
  15. 15.
    Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2002) Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res 88:25–30CrossRefPubMedGoogle Scholar
  16. 16.
    Theophanides T, Anastassopoulou J (2002) Copper and carcinogenesis. Crit Rev Oncol Hematol 42:57–64CrossRefPubMedGoogle Scholar
  17. 17.
    Castiglioni S, Maier JA (2011) Magnesium and cancer: a dangerous liason. Magnes Res 24:S92–S100PubMedGoogle Scholar
  18. 18.
    Rayssiguier Y, Durlach J, Gueux E, Rock E, Mazur A (1993) Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes Res 6:369–378PubMedGoogle Scholar
  19. 19.
    Anastassopoulou J, Theophanides T (2002) Magnesium–DNA interactions and the possible relation of magnesium to carcinogenesis. irradiation and free radicals. Crit Rev Oncol Hematol 42:79–91CrossRefPubMedGoogle Scholar
  20. 20.
    Wolf FI, Maier JA, Nasulewicz A, Feillet-Coudray C, Simonacci M et al (2007) Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys 458:24–32CrossRefPubMedGoogle Scholar
  21. 21.
    Moncayo R, Kroiss A, Oberwinkler M, Karakolcu F, Starzinger M et al (2008) The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord 8:2PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG et al (1989) Prediagnostic serum selenium in a case–control study of thyroid cancer. Int J Epidemiol 18:45–49CrossRefPubMedGoogle Scholar
  23. 23.
    Leung PL, Li XL (1996) Multielement analysis in serum of thyroid cancer patients before and after a surgical operation. Biol Trace Elem Res 51:259–266CrossRefPubMedGoogle Scholar
  24. 24.
    Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2003) Copper, zinc, and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol Trace Elem Res 93:9–18CrossRefPubMedGoogle Scholar
  25. 25.
    Kosova F, Cetin B, Akinci M, Aslan S, Seki A et al (2012) Serum copper levels in benign and malignant thyroid diseases. Bratisl Lek Listy 113:718–720PubMedGoogle Scholar
  26. 26.
    Al-Sayer H, Mathew TC, Asfar S, Khourshed M, Al-Bader A et al (2004) Serum changes in trace elements during thyroid cancers. Mol Cell Biochem 260:1–5CrossRefPubMedGoogle Scholar
  27. 27.
    Przybylik-Mazurek E, Zagrodzki P, Kuzniarz-Rymarz S, Hubalewska-Dydejczyk A (2011) Thyroid disorders-assessments of trace elements, clinical, and laboratory parameters. Biol Trace Elem Res 141:65–75CrossRefPubMedGoogle Scholar
  28. 28.
    Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, et al. (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7: iii–x, 1–173Google Scholar
  29. 29.
    Rayman MP (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64:527–542CrossRefPubMedGoogle Scholar
  30. 30.
    Combs GF Jr (2005) Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 135:343–347PubMedGoogle Scholar
  31. 31.
    Al-Saleh I, Billedo G (2006) Determination of selenium concentration in serum and toenail as an indicator of selenium status. Bull Environ Contam Toxicol 77:155–163CrossRefPubMedGoogle Scholar
  32. 32.
    Xia Y, Hill KE, Byrne DW, Xu J, Burk RF (2005) Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 81:829–834PubMedGoogle Scholar
  33. 33.
    Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE et al (1990) A prospective study of selenium status and breast cancer risk. JAMA 264:1128–1131CrossRefPubMedGoogle Scholar
  34. 34.
    Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L (2003) Selenium in breast cancer. Oncology 64:227–231CrossRefPubMedGoogle Scholar
  35. 35.
    Harris HR, Bergkvist L, Wolk A (2012) Selenium intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Res Treat 134:1269–1277CrossRefPubMedGoogle Scholar
  36. 36.
    Moradi M, Hassan Eftekhari M, Talei A, Rajaei Fard A (2009) A comparative study of selenium concentration and glutathione peroxidase activity in normal and breast cancer patients. Public Health Nutr 12:59–63CrossRefPubMedGoogle Scholar
  37. 37.
    Rejali L, Jaafar MH, Ismail NH (2007) Serum selenium level and other risk factors for breast cancer among patients in a Malaysian hospital. Environ Health Prev Med 12:105–110PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Aichler M, Algul H, Behne D, Holzlwimmer G, Michalke B et al (2007) Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-alpha p53+/ mice. Carcinogenesis 28:2002–2007CrossRefPubMedGoogle Scholar
  39. 39.
    Fischer JL, Mihelc EM, Pollok KE, Smith ML (2007) Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther 6:355–361CrossRefPubMedGoogle Scholar
  40. 40.
    Wang D, Feng JF, Zeng P, Yang YH, Luo J et al (2011) Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr Relat Cancer 18:773–782PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Brem S (1999) Angiogenesis and cancer control: from concept to therapeutic trial. Cancer Control 6:436–458PubMedGoogle Scholar
  42. 42.
    Blazewicz A, Dolliver W, Sivsammye S, Deol A, Randhawa R et al (2010) Determination of cadmium, cobalt, copper, iron, manganese, and zinc in thyroid glands of patients with diagnosed nodular goitre using ion chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 878:34–38CrossRefPubMedGoogle Scholar
  43. 43.
    Kasprzak KS, Diwan BA, Rice JM (1994) Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology 90:129–140CrossRefPubMedGoogle Scholar
  44. 44.
    Patiroglu T, Sahin G, Kontas O, Uzum K, Saraymen R (1997) Protective effect of magnesium supplementation on experimental 3-methyl cholanthrene-induced fibrosarcoma and changes in tissue magnesium distribution during carcinogenesis in rats. Biol Trace Elem Res 56:179–185CrossRefPubMedGoogle Scholar
  45. 45.
    Tanaka T, Shinoda T, Yoshimi N, Niwa K, Iwata H et al (1989) Inhibitory effect of magnesium hydroxide on methylazoxymethanol acetate-induced large bowel carcinogenesis in male F344 rats. Carcinogenesis 10:613–616CrossRefPubMedGoogle Scholar
  46. 46.
    Wang A, Yoshimi N, Tanaka T, Mori H (1993) Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett 75:73–78CrossRefPubMedGoogle Scholar
  47. 47.
    Bois P, Sandborn EB, Messier PE (1969) A study of thymic lymphosarcoma developing in magnesium-deficient rats. Cancer Res 29:763–775PubMedGoogle Scholar
  48. 48.
    Hartwig A (2001) Role of magnesium in genomic stability. Mutat Res 475:113–121CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of General Surgery, Guangzhou First People’s HospitalGuangzhou Medical UniversityYuexiu DistrictPeople’s Republic of China

Personalised recommendations